Home Clinical Psychology & Psychotherapy Join Endoverse: The UK’s First Organisation Dedicated to the Study of Endocannabinology

Join Endoverse: The UK’s First Organisation Dedicated to the Study of Endocannabinology

Reading Time: 3 minutes

Train as a clinical consultant with Endoverse’s Endocannabinology Balance Approach Programme – applications now open for the 2nd July 2021 course.

Endoverse has announced its next round of endocannabinology training and is now accepting applications.

Experts from the organisation, which launched in the UK in 2019, will train and develop participants’ skills, confidence, and knowledge of endocannabinology and the endocannabinoid system (ECS).

The qualification will equip trainees with the tools to apply the Endocannabinology Balance Approach to patients in a clinical setting, with access to an online consultancy HIPAA, GDPR compliant platform and integrated booking and payment solutions for online and face-to-face consultations.

The course is open to those who want to positively impact patient health using healing-oriented medicine and are either educated to degree level, currently working with clients across the health and well-being space or training to do so. Endoverse is open to receiving applications from a wide range of candidates with attitude, motivation, and enthusiasm key consideration criteria.

Endocannabinology is the study of the function of the ECS and research has linked this key internal system to a number of processes and functions including sleep, the immune system, digestion, fertility, and stress.

The Endoverse team believes the key to optimum health is ensuring the correct balance of the ECS. Through a mixture of consultations, lifestyle adaptations, and supplements, in particular fatty acids and Vitamin D, Endoverse works with patients to achieve their health goals.

At the end of the training, selected participants will be offered the opportunity to become Endoverse academy accredited trainers with access to an online training platform. These candidates will then be able to train other professionals to become Endoverse clinical consultants.

Dr Kristina Ranna, Chief Medical Officer at Endoverse said: ‘We are thrilled to announce our second round of training and look forward to receiving applications from across the globe.

‘Endoverse is a pioneer in the health and well-being space, on a mission to educate and inform people about the ECS – such a crucial internal system with massive impacts on health and well-being, yet so rarely explored in modern medicine.

‘We are looking for participants who are passionate about helping others and who want to add real value to their CV. Our team will fully support all trainees throughout their journey with any questions they may have and each training session will last 90 minutes.

‘Endoverse is currently launching a range of initiatives – including B2C webinars and retreats as well as B2B training and packages to educate the fast-growing cannabis industry about the ECS, ensuring businesses are providing clear messaging to consumers.

‘Those taking part in the training will be joining us at an exciting time with huge potential for future opportunities.’

The course, which starts on 2nd July at 4pm and ends on 27th August, will cover eight modules including physiology, endocannabidiome disbalance, diet, and stress. After each module, participants will take part in a quiz before gaining access to the next module.

The deadline for applications is 30th June and costs £1000 – more information can be found on the application page.

At Endoverse, ECS balance is achieved through lifestyle modifications, including attaining an ideal ratio of omega 3, omega 6, and other fatty acids. Applying these modifications correctly and with the assistance of an endocannabinologist could be the key to improving many common health conditions, such as obesity.

Dr Ranna explains: ‘Despite the popularity of clinical endocannabinoid system deficiency syndrome, we know that the real problem of western societies is an overactivated ECS, which long-term induces metabolic syndrome. This syndrome is characterised by increased body mass index, increased blood sugar levels and blood pressure, and a disturbed serum level of cholesterol and triglycerides.

‘Consequences of metabolic syndrome are diabetes, cardiovascular disorders, stroke, and a risk factor for cancer. There is also a clear link between metabolic syndrome and COVID-19 severity. This is related to the higher activity of CB1 receptors, which is influenced by a disrupted ratio between omega 3 and omega 6 fatty acids.’

Anyone who wants to learn more about Endoverse or any businesses wishing to work with the company can email them at: company@endoverse.com.

© Copyright 2014–2034 Psychreg Ltd